EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pfizer's Enterprise Value is $289,287 Mil.
Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was $33,772 Mil. Therefore, Pfizer's EV-to-EBIT for today is 8.57.
The historical rank and industry rank for Pfizer's EV-to-EBIT or its related term are showing as below:
PFE'
s EV-to-EBIT Range Over the Past 10 Years
Min: 8.6 Med: 16.98 Max: 3034.67
Current: 8.62
During the past 13 years, the highest EV-to-EBIT of Pfizer was 3034.67. The lowest was 8.60. And the median was 16.98.
PFE's EV-to-EBIT is ranked better than 75.41% of 675
companies
in the Drug Manufacturers industry
Industry Median: 16.06
vs PFE: 8.62
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Pfizer's Enterprise Value for the quarter that ended in Mar. 2022 was $300,862 Mil.
Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was $33,772 Mil. Pfizer's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was 11.23%.
Pfizer EV-to-EBIT Historical Data
The historical data trend for Pfizer's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Pfizer Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
EV-to-EBIT
16.80
52.89
19.15
27.25
13.20
Pfizer Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
EV-to-EBIT
15.90
11.35
13.20
10.39
-
Competitive Comparison
For the Drug Manufacturers - General subindustry, Pfizer's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pfizer EV-to-EBIT Distribution
For the Drug Manufacturers industry and Healthcare sector, Pfizer's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Pfizer's EV-to-EBIT falls into.
Pfizer's current Enterprise Value is $289,287 Mil.
Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $33,772 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pfizer (NYSE:PFE) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Pfizer's Enterprise Value for the quarter that ended in Mar. 2022 was $300,862 Mil.
Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $33,772 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pfizer EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Pfizer's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.21(0.42%) Volume: 12,067,863 10:08PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:PFE has been successfully added to your 
